文献速递泌尿与男性生殖病理细胞病理与分子病理

肾病变细针穿刺(FNA)性能特征的系统综述:是时候建立标准化分类系统了

A systematic review on performance characteristics of FNA of renal lesions: It is time for a standardized classification system.
PubMed 文献 · Cancer Cytopathol · 2024-05-07

该研究系统检索并分析了肾细针穿刺(FNA)文献,纳入23项研究共2231例FNA病例,按拟议分类系统重新归类并计算恶性肿瘤风险。结果显示不同分类类别恶性肿瘤风险为16.6%至96.9%,FNA准确率91%–95%、敏感度90.9%–96.7%、特异度82%–92%。作者据此提出包含各类别及对应恶性肿瘤风险的新报告系统。

要点

  • 肾FNA各分类类别恶性肿瘤风险为16.6%至96.9%,非诊断类别为65.4%。
  • 不同情景下肾FNA准确率91%–95%、敏感度90.9%–96.7%、特异度82%–92%。
  • 作者基于文献提出包含类别及恶性肿瘤风险的新报告系统。

核心结论

  • 肾细胞学需要标准化报告,以提高敏感度和准确率、减少不确定诊断并改变肾病变管理策略。
  • 基于现有文献提出了包含各类别及对应恶性肿瘤风险的新报告系统。

研究设计与样本

  • 系统综述:系统检索肾FNA已发表文献,提取FNA与组织学诊断数据并分类,计算恶性肿瘤风险。
  • 3766项潜在相关研究中23项符合纳入标准,共纳入2231例FNA病例。

主要发现

  • 2231例FNA重新归类后:非诊断142例(6.36%)、非肿瘤性270例(12.1%)、良性肿瘤271例(12.14%)。
  • 嗜酸细胞型恶性潜能未知肾肿瘤65例(2.91%)、意义未定的异型性25例(1.12%)、可疑恶性60例(2.68%)、恶性1398例(62.66%)。
  • 上述类别恶性肿瘤风险分别为65.4%、18.1%、16.6%、16.9%、60%、73.3%、96.9%。
  • 不同情景下肾FNA准确率91%–95%、敏感度90.9%–96.7%、特异度82%–92%。

关键数值与推荐

  • 非诊断类别恶性肿瘤风险65.4%,非肿瘤性18.1%,良性肿瘤16.6%。
  • 嗜酸细胞型恶性潜能未知肾肿瘤恶性肿瘤风险16.9%,意义未定异型性60%,可疑恶性73.3%,恶性96.9%。
  • 不同情景下肾FNA准确率91%–95%、敏感度90.9%–96.7%、特异度82%–92%。

临床怎么用

  • 肾FNA报告可采用所提出的分类系统,各类别附带恶性肿瘤风险以辅助临床管理。
  • 标准化报告有望提高肾细胞学敏感度和准确率、减少不确定诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence of renal tumors has steadily increased over the past decade. In this study, the authors performed a systematic review and analysis of the literature on renal fine-needle aspiration (FNA) to determine its performance and explore whether a standardized classification system can be used for reporting renal FNA cytology. METHODS: A systematic search of published articles on renal FNA was conducted. The data on FNA and histologic diagnosis were extracted and categorized, and the risk of malignancy was calculated. Different scenarios were used to estimate FNA performance statistics. RESULTS: Of the 3766 potentially relevant studies, 23 met the inclusion criteria of the study. The 2231 FNA cases included were re-categorized according to the classification system, rendering 142 (6.36%) nondiagnostic, 270 (12.1%) nonneoplastic, 271 (12.14%) benign neoplasm, 65 (2.91%) renal neoplasm with unknown malignant potential, oncocytic type, 25 (1.12%) atypia of undetermined significance, 60 (2.68%) suspicious for malignancy, and 1398 (62.66%) malignant FNA diagnoses. The risk of malignancy in these cases was 65.4%, 18.1%, 16.6%, 16.9%, 60%, 73.3%, and 96.9%, respectively. According to the classification system, the study indicated that the accuracy of renal FNA was between 91% and 95%, the sensitivity was 90.9%-96.7%, and the specificity was 82%-92% in different scenarios. CONCLUSIONS: There is a need for a standardized reporting in renal cytology that will improve the sensitivity and accuracy of renal cytology, reduce the rate of indeterminate diagnoses, and alter the management strategies of renal lesions. Based on the available literature, a new reporting system is proposed, including categories with an associated risk of malignancy.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Katipoglu K, Kilic I, Kurtulan O, et al. A systematic review on performance characteristics of FNA of renal lesions: It is time for a standardized classification system. Cancer Cytopathol. 2024. PMID: 38713617. doi:10.1002/cncy.22826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。